Covered recipient · General Payments record
JOHN D LEDBETTER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,473.17
- Reported across 507 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $442.82 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $229.97 | 2 |
| Corcept Therapeutics | $103.69 | 1 |
| Phathom Pharmaceuticals, Inc. | $25.22 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.70 | 1 |
| Acerta Pharma LLC | $17.49 | 1 |
| Lilly USA, LLC | $17.46 | 1 |
| PFIZER INC. | $17.39 | 1 |
| Exact Sciences Corporation | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17.49 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104767942 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086254780 | CMS |
| Corcept Therapeutics | $103.69 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117785121 | CMS |
| Exact Sciences Corporation | $13.90 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114751637 | CMS |
| Lilly USA, LLC | $17.46 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135054476 | CMS |
| Novo Nordisk Inc | $104.97 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096872836 | CMS |
| Novo Nordisk Inc | $125.00 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097635536 | CMS |
| PFIZER INC. | $17.39 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131220318 | CMS |
| Phathom Pharmaceuticals, Inc. | $25.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151087211 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.